[The pleiotropic drug resistance phenotype: role of reverting agents "in vitro" and "in vivo"]

MeSH terms

• ATP Binding Cassette Transporter, Subfamily B, Member 1
• Acute Disease
• Adult
• Antineoplastic Combined Chemotherapy Protocols / pharmacokinetics
• Antineoplastic Combined Chemotherapy Protocols / pharmacology
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Carrier Proteins / antagonists & inhibitors*
• Carrier Proteins / metabolism
• Cefoperazone / pharmacology*
• Child
• Cyclosporine / pharmacology*
• Doxorubicin / pharmacology
• Drug Evaluation
• Drug Synergism
• Humans
• Leukemia / drug therapy*
• Leukemia / enzymology
• Membrane Glycoproteins / antagonists & inhibitors*
• Membrane Glycoproteins / metabolism
• Neoplasm Proteins / antagonists & inhibitors*
• Neoplasm Proteins / metabolism
• Neoplastic Stem Cells / drug effects
• Neoplastic Stem Cells / metabolism
• Nicardipine / pharmacology*
• Nicardipine / therapeutic use
• Phenotype
• RNA, Messenger / analysis
• RNA, Neoplasm / analysis
• Verapamil / pharmacology*